These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4609636)

  • 1. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
    Detre KM; Shaw L
    Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636
    [No Abstract]   [Full Text] [Related]  

  • 2. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 3. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
    JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847
    [No Abstract]   [Full Text] [Related]  

  • 4. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 5. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 6. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 8. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
    Savenkov PM
    Kardiologiia; 1967 Apr; 7(4):50-3. PubMed ID: 5598475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatment of hyperlipemia. Indications and modern preparations].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.
    Coronary Drug Project Research Group
    N Engl J Med; 1977 May; 296(21):1185-90. PubMed ID: 323705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hyperlipidemic states.
    Strisower EH; Adamson G; Strisower B
    Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for use of lipid-lowering drugs.
    Dayton S
    Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary prevention of coronary heart disease: a critique.
    Borhani NO
    Am J Cardiol; 1977 Aug; 40(2):251-9. PubMed ID: 195453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of lipid disorders.
    Krikler DM
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():72-7. PubMed ID: 4582173
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 20. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.